
Tariff-related Litigation Update – 6/27
Member-only overview of IEEPA reciprocal & “fentanyl” tariffs under EO 14257, summarizing key federal court challenges and rulings through June 17, 2025.
Our experts are continually producing new and valuable materials for the medtech community.
Compliance
AdvaMed® has developed revisions to the AdvaMed® Code of Ethics to address evolving compliance and legal standards, account for innovative value-based care arrangements, and incorporate additional provisions on risk areas specific to medical technology companies.
Member-only overview of IEEPA reciprocal & “fentanyl” tariffs under EO 14257, summarizing key federal court challenges and rulings through June 17, 2025.
Member-only summary of IEEPA “fentanyl” and reciprocal tariffs under EO 14257, plus status of related legal challenges across federal courts through June 17, 2025.
Explore the latest IEEPA tariff developments and legal challenges, including executive orders on fentanyl tariffs and reciprocal duties affecting global MedTech trade.
USTR proposes new China tariffs; FDA, CMS, and White House actions could reshape MedTech—member input needed by June 10.
AdvaMed® members receive full access to our library of medtech resources. Become a member to receive this and countless other benefits.